-
1
-
-
84862915330
-
Regulation of the inflammatory response: Enhancing neutrophil infiltration under chronic inflammatory conditions
-
Bian Z, Guo Y, Ha B, Zen K, Liu Y. Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions. J. Immunol. 188(2), 844-853 (2012).
-
(2012)
J. Immunol.
, vol.188
, Issue.2
, pp. 844-853
-
-
Bian, Z.1
Guo, Y.2
Ha, B.3
Zen, K.4
Liu, Y.5
-
2
-
-
0032519925
-
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGFbeta, PGE2, and PAF
-
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGFbeta, PGE2, and PAF. J. Clin. Invest. 101(4), 890-898 (1998).
-
(1998)
J. Clin. Invest.
, vol.101
, Issue.4
, pp. 890-898
-
-
Fadok, V.A.1
Bratton, D.L.2
Konowal, A.3
Freed, P.W.4
Westcott, J.Y.5
Henson, P.M.6
-
3
-
-
0035877019
-
Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites
-
Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166(12), 7556-7562 (2001).
-
(2001)
J. Immunol.
, vol.166
, Issue.12
, pp. 7556-7562
-
-
Abe, R.1
Donnelly, S.C.2
Peng, T.3
Bucala, R.4
Metz, C.N.5
-
4
-
-
0141500805
-
-
Saunders/Elsevier Health Sciences, PA, USA
-
Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology (8th Edition). Saunders/Elsevier Health Sciences, PA, USA, 31-58 (2007).
-
(2007)
Robbins Basic Pathology (8th Edition)
, pp. 31-58
-
-
Kumar, V.1
Abbas, A.K.2
Fausto, N.3
Mitchell, R.N.4
-
5
-
-
54349096867
-
Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis
-
Fichtner-Feigl S, Strober W, Geissler EK, Schlitt HJ. Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol. 1, S24-S27 (2008).
-
(2008)
Mucosal Immunol.
, vol.1
, pp. S24-S27
-
-
Fichtner-Feigl, S.1
Strober, W.2
Geissler, E.K.3
Schlitt, H.J.4
-
6
-
-
66549126476
-
Neutrophil apoptosis and the resolution of infection
-
Kennedy A, Deleo F. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43(1-3), 25-61 (2009).
-
(2009)
Immunol. Res.
, vol.43
, Issue.1-3
, pp. 25-61
-
-
Kennedy, A.1
Deleo, F.2
-
7
-
-
67449168081
-
Disruption of Nrf2 Impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice
-
Reddy NM, Kleeberger SR, Kensler TW, Yamamoto M, Hassoun PM, Reddy SP. Disruption of Nrf2 Impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J. Immunol. 182(11), 7264-7271 (2009).
-
(2009)
J. Immunol.
, vol.182
, Issue.11
, pp. 7264-7271
-
-
Reddy, N.M.1
Kleeberger, S.R.2
Kensler, T.W.3
Yamamoto, M.4
Hassoun, P.M.5
Reddy, S.P.6
-
8
-
-
84855172814
-
The pathogenesis of rheumatoid arthritis
-
Mcinnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365(23), 2205-2219 (2011).
-
(2011)
N. Engl. J. Med.
, vol.365
, Issue.23
, pp. 2205-2219
-
-
Mcinnes, I.B.1
Schett, G.2
-
9
-
-
33745775434
-
Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis
-
Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390-407 (2006).
-
(2006)
Nat. Clin. Pract. Gastroenterol. Hepatol.
, vol.3
, pp. 390-407
-
-
Sartor, R.B.1
-
10
-
-
84864776533
-
Pathogenesis of chronic obstructive pulmonary disease
-
Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J. Clin. Invest. 122(8), 2749-2755 (2012).
-
(2012)
J. Clin. Invest.
, vol.122
, Issue.8
, pp. 2749-2755
-
-
Tuder, R.M.1
Petrache, I.2
-
12
-
-
0033951612
-
Economic burden of rheumatoid arthritis: A systematic review
-
Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 39(1), 28-33 (2000).
-
(2000)
Rheumatology (Oxford)
, vol.39
, Issue.1
, pp. 28-33
-
-
Cooper, N.J.1
-
13
-
-
79958835184
-
Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: A review
-
Park KT, Bass D. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review. Inflammat. Bowel Dis. 17(7), 1603-1609 (2011).
-
(2011)
Inflammat. Bowel Dis.
, vol.17
, Issue.7
, pp. 1603-1609
-
-
Park, K.T.1
Bass, D.2
-
14
-
-
0037440789
-
Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study
-
Lajas C, Abasolo L, Bellajdel B et al. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Care Res. 49(1), 64-70 (2003).
-
(2003)
Arthritis Care Res.
, vol.49
, Issue.1
, pp. 64-70
-
-
Lajas, C.1
Abasolo, L.2
Bellajdel, B.3
-
15
-
-
79958076320
-
Health care costs and their predictors of inflammatory bowel diseases in Germany
-
Prenzler A, Bokemeyer B, Schulenburg JM, Mittendorf T. Health care costs and their predictors of inflammatory bowel diseases in Germany. Eur. J. Health Econ. 12(3), 273-283 (2011).
-
(2011)
Eur. J. Health Econ.
, vol.12
, Issue.3
, pp. 273-283
-
-
Prenzler, A.1
Bokemeyer, B.2
Schulenburg, J.M.3
Mittendorf, T.4
-
16
-
-
84856012240
-
Socioeconomic burden of immune-mediated inflammatory diseases-focusing on work productivity and disability
-
Jacobs P, Bissonnette R, Guenther LC. Socioeconomic burden of immune-mediated inflammatory diseases-focusing on work productivity and disability. J. Rheumatol. 88, 55-61 (2011).
-
(2011)
J. Rheumatol.
, vol.88
, pp. 55-61
-
-
Jacobs, P.1
Bissonnette, R.2
Guenther, L.C.3
-
17
-
-
77649223361
-
Societal cost of rheumatoid arthritis patients in the US
-
Birnbaum H, Pike C, Kaufman R, Maynchenko M, Kidolezi Y, Cifaldi M. Societal cost of rheumatoid arthritis patients in the US. Curr. Med. Res. Opin. 26(1), 77-90 (2010).
-
(2010)
Curr. Med. Res. Opin.
, vol.26
, Issue.1
, pp. 77-90
-
-
Birnbaum, H.1
Pike, C.2
Kaufman, R.3
Maynchenko, M.4
Kidolezi, Y.5
Cifaldi, M.6
-
18
-
-
0036680727
-
Batch and continuous fluid bed coating-review and state of the art
-
Teunou E, Poncelet D. Batch and continuous fluid bed coating-review and state of the art. J. Food Eng. 53(4), 325-340 (2002).
-
(2002)
J. Food Eng.
, vol.53
, Issue.4
, pp. 325-340
-
-
Teunou, E.1
Poncelet, D.2
-
19
-
-
85046075253
-
-
Rose NR, Mackay IR (Eds). Elsevier/Academic Press, Amsterdam, The Netherlands
-
Smolen JS, Redlich K. The Autoimmune Diseases (5th Edition). Rose NR, Mackay IR (Eds). Elsevier/Academic Press, Amsterdam, The Netherlands, 511-523 (2006).
-
(2006)
The Autoimmune Diseases (5th Edition)
, pp. 511-523
-
-
Smolen, J.S.1
Redlich, K.2
-
20
-
-
70350531479
-
Prospective new biological therapies for rheumatoid arthritis
-
͈enolt L, Vencovský J, Pavelka K, Ospelt C, Gay S. Prospective new biological therapies for rheumatoid arthritis. Autoimmun. Rev. 9(2), 102-107 (2009).
-
(2009)
Autoimmun. Rev.
, vol.9
, Issue.2
, pp. 102-107
-
-
͈enolt, L.1
Vencovský, J.2
Pavelka, K.3
Ospelt, C.4
Gay, S.5
-
21
-
-
34248207245
-
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: Rationale and mechanisms of action
-
Bayry J, Kaveri SV, Kazatchkine MD, Lacroix-Desmazes S. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat. Clin. Pract. Rheumatol. 3(5), 262-272 (2007).
-
(2007)
Nat. Clin. Pract. Rheumatol.
, vol.3
, Issue.5
, pp. 262-272
-
-
Bayry, J.1
Kaveri, S.V.2
Kazatchkine, M.D.3
Lacroix-Desmazes, S.4
-
23
-
-
10344255627
-
Signal transduction pathways: New targets for treating rheumatoid arthritis
-
Morel J, Berenbaum F. Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 71(6), 503-510 (2004).
-
(2004)
Joint Bone Spine
, vol.71
, Issue.6
, pp. 503-510
-
-
Morel, J.1
Berenbaum, F.2
-
24
-
-
59649114148
-
Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis
-
Cohen SB, Cheng T-T, Chindalore V et al. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis Rheumat. 60(2), 335-344 (2009).
-
(2009)
Arthritis Rheumat.
, vol.60
, Issue.2
, pp. 335-344
-
-
Cohen, S.B.1
Cheng, T.-T.2
Chindalore, V.3
-
25
-
-
55849114400
-
Treatment of rheumatoid arthritis with a Syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial
-
Weinblatt ME, Kavanaugh A, Burgos-Vargas R et al. Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis Rheumat. 58(11), 3309-3318 (2008).
-
(2008)
Arthritis Rheumat.
, vol.58
, Issue.11
, pp. 3309-3318
-
-
Weinblatt, M.E.1
Kavanaugh, A.2
Burgos-Vargas, R.3
-
26
-
-
81855170441
-
Nanomedicine(s) under the microscope
-
Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol. Pharm. 8(6), 2101-2141 (2011).
-
(2011)
Mol. Pharm.
, vol.8
, Issue.6
, pp. 2101-2141
-
-
Duncan, R.1
Gaspar, R.2
-
27
-
-
1942423636
-
A transient diffusion model yields unitary gap junctional permeabilities from images of cell-to-cell fluorescent dye transfer between xenopus oocytes
-
Nitsche JM, Chang H-C, Weber PA, Nicholson BJ. A transient diffusion model yields unitary gap junctional permeabilities from images of cell-to-cell fluorescent dye transfer between xenopus oocytes. Biophys. J. 86(4), 2058-2077 (2004).
-
(2004)
Biophys. J.
, vol.86
, Issue.4
, pp. 2058-2077
-
-
Nitsche, J.M.1
Chang, H.-C.2
Weber, P.A.3
Nicholson, B.J.4
-
28
-
-
1942485065
-
The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities
-
Weber PA, Chang H-C, Spaeth KE, Nitsche JM, Nicholson BJ. The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. Biophys. J. 87(2), 958-973 (2004).
-
(2004)
Biophys. J.
, vol.87
, Issue.2
, pp. 958-973
-
-
Weber, P.A.1
Chang, H.-C.2
Spaeth, K.E.3
Nitsche, J.M.4
Nicholson, B.J.5
-
29
-
-
0032103164
-
Gap junction channels in the cardiovascular system: Pharmacological and physiological modulation
-
Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol. Sci. 19(6), 229-241 (1998).
-
(1998)
Trends Pharmacol. Sci.
, vol.19
, Issue.6
, pp. 229-241
-
-
Dhein, S.1
-
30
-
-
0014097086
-
Hexagonal array of subunits in intercellular junctions of the mouse heart and liver
-
Revel JP, Karnovsky MJ. Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J. Cell Biol. 33(3), C7-C12 (1967).
-
(1967)
J. Cell Biol.
, vol.33
, Issue.3
, pp. C7-C12
-
-
Revel, J.P.1
Karnovsky, M.J.2
-
31
-
-
0034993240
-
The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting
-
Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41(1), 189-207 (2001).
-
(2001)
Adv. Enzyme Regul.
, vol.41
, Issue.1
, pp. 189-207
-
-
Maeda, H.1
-
32
-
-
0029150245
-
Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
-
Yuan F, Dellian M, Fukumura D et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55(17), 3752-3756 (1995).
-
(1995)
Cancer Res.
, vol.55
, Issue.17
, pp. 3752-3756
-
-
Yuan, F.1
Dellian, M.2
Fukumura, D.3
-
33
-
-
84937398939
-
-
Kumar A, Mansour HM, Friedman A, Blough ER (Eds). CRC Press/Taylor & Francis Group, FL, USA
-
Castro E, Kumar A. Nanomedicine in Drug Delivery. Kumar A, Mansour HM, Friedman A, Blough ER (Eds). CRC Press/Taylor & Francis Group, FL, USA, 1-22 (2013).
-
(2013)
Nanomedicine in Drug Delivery
, pp. 1-22
-
-
Castro, E.1
Kumar, A.2
-
35
-
-
77952220675
-
Protein PEGylation, basic science and biological applications
-
Veronese F (Ed.). Birkhäuser Verlag, Basel, Switzerland
-
Veronese F, Mero A, Pasut G. Protein PEGylation, basic science and biological applications. In: PEGylated Protein Drugs: Basic Science and Clinical Applications. Veronese F (Ed.). Birkhäuser Verlag, Basel, Switzerland, 11-31 (2009).
-
(2009)
PEGylated Protein Drugs: Basic Science and Clinical Applications
, pp. 11-31
-
-
Veronese, F.1
Mero, A.2
Pasut, G.3
-
36
-
-
0035005359
-
PEGylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy
-
Gabizon AA. PEGylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 19(4), 424-436 (2001).
-
(2001)
Cancer Invest.
, vol.19
, Issue.4
, pp. 424-436
-
-
Gabizon, A.A.1
-
37
-
-
77952575335
-
Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects
-
Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug. Chem. 21(5), 797-802 (2010).
-
(2010)
Bioconjug. Chem.
, vol.21
, Issue.5
, pp. 797-802
-
-
Maeda, H.1
-
38
-
-
84880757123
-
The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect
-
Maeda H. The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci. 104(7), 779-789 (2013).
-
(2013)
Cancer Sci.
, vol.104
, Issue.7
, pp. 779-789
-
-
Maeda, H.1
-
39
-
-
84856661263
-
Studies on the cell biology of interendothelial cell gaps
-
Ochoa CD, Stevens T. Studies on the cell biology of interendothelial cell gaps. Am. J. Physiol. 302(3), L275-L286 (2012).
-
(2012)
Am. J. Physiol.
, vol.302
, Issue.3
, pp. L275-L286
-
-
Ochoa, C.D.1
Stevens, T.2
-
40
-
-
74549156006
-
Chemokines and cytokines in inflammatory angiogenesis
-
Seed M, Walsh D (Eds). Birkhäuser Verlag, Basel, Switzerland
-
Szekanecz Z, Koch A. Chemokines and cytokines in inflammatory angiogenesis. In: Angiogenesis in Inflammation: Mechanisms and Clinical Correlates. Seed M, Walsh D (Eds). Birkhäuser Verlag, Basel, Switzerland, 83-98 (2008).
-
(2008)
Angiogenesis in Inflammation: Mechanisms and Clinical Correlates
, pp. 83-98
-
-
Szekanecz, Z.1
Koch, A.2
-
41
-
-
0033063325
-
VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis
-
Sans M, Panés J, Ardite E et al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology 116(4), 874-883 (1999).
-
(1999)
Gastroenterology
, vol.116
, Issue.4
, pp. 874-883
-
-
Sans, M.1
Panés, J.2
Ardite, E.3
-
42
-
-
79955619445
-
Actively targeted lowdose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis
-
Koo O, Rubinstein I, Önyüksel H. Actively targeted lowdose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharm. Res. 28(4), 776-787 (2011).
-
(2011)
Pharm. Res.
, vol.28
, Issue.4
, pp. 776-787
-
-
Koo, O.1
Rubinstein, I.2
Önyüksel, H.3
-
43
-
-
77955409183
-
Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis
-
Martinez-Lostao L, Garcia-Alvarez F, Basanez G et al. Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. Arthritis Rheumat. 62(8), 2272-2282 (2010).
-
(2010)
Arthritis Rheumat.
, vol.62
, Issue.8
, pp. 2272-2282
-
-
Martinez-Lostao, L.1
Garcia-Alvarez, F.2
Basanez, G.3
-
44
-
-
85015549976
-
-
ClinicalTrials.gov. www.clinicaltrials.gov
-
-
-
-
45
-
-
84875493753
-
Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
-
Chiong HS, Yong YK, Ahmad Z et al. Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages. Int. J. Nanomedicine 8, 1245-1255 (2013).
-
(2013)
Int. J. Nanomedicine
, vol.8
, pp. 1245-1255
-
-
Chiong, H.S.1
Yong, Y.K.2
Ahmad, Z.3
-
46
-
-
84893749660
-
Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments
-
Turk CTS, Oz UC, Serim TM, Hascicek C. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments. AAPS PharmSciTech 15(1), 161-176 (2014).
-
(2014)
AAPS PharmSciTech
, vol.15
, Issue.1
, pp. 161-176
-
-
Turk, C.T.S.1
Oz, U.C.2
Serim, T.M.3
Hascicek, C.4
-
47
-
-
84908281062
-
An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase
-
James LRA, Xu Z-Q, Sluyter R et al. An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase. J. Inorg. Biochem. 142(0), 28-38 (2015).
-
(2015)
J. Inorg. Biochem.
, vol.142
, pp. 28-38
-
-
James, L.R.A.1
Xu, Z.-Q.2
Sluyter, R.3
-
48
-
-
79958207519
-
Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis
-
Hofkens W, Grevers LC, Walgreen B et al. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. J. Control. Release 152(3), 363-369 (2011).
-
(2011)
J. Control. Release
, vol.152
, Issue.3
, pp. 363-369
-
-
Hofkens, W.1
Grevers, L.C.2
Walgreen, B.3
-
49
-
-
79961062552
-
Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis
-
Hofkens W, Storm G, Van Den Berg WB, Van Lent PL. Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis. Int. J. Pharm. 416(2), 486-492 (2011).
-
(2011)
Int. J. Pharm.
, vol.416
, Issue.2
, pp. 486-492
-
-
Hofkens, W.1
Storm, G.2
Van Den Berg, W.B.3
Van Lent, P.L.4
-
50
-
-
80051904807
-
Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: Comparison of prednisolone with budesonide
-
Hofkens W, Van Den Hoven JM, Pesman GJ et al. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide. Int. J. Pharm. 416(2), 493-498 (2011).
-
(2011)
Int. J. Pharm.
, vol.416
, Issue.2
, pp. 493-498
-
-
Hofkens, W.1
Van Den Hoven, J.M.2
Pesman, G.J.3
-
51
-
-
84874522489
-
Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation
-
Hofkens W, Schelbergen R, Storm G, Van Den Berg WB, Van Lent PL. Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation. PLoS ONE 8(2), e54016 (2013).
-
(2013)
PLoS ONE
, vol.8
, Issue.2
, pp. e54016
-
-
Hofkens, W.1
Schelbergen, R.2
Storm, G.3
Van Den Berg, W.B.4
Van Lent, P.L.5
-
52
-
-
1842505688
-
Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis
-
Metselaar JM, Van Den Berg WB, Holthuysen AE, Wauben MH, Storm G, Van Lent PL. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheumat. Dis. 63(4), 348-353 (2004).
-
(2004)
Ann. Rheumat. Dis.
, vol.63
, Issue.4
, pp. 348-353
-
-
Metselaar, J.M.1
Van Den Berg, W.B.2
Holthuysen, A.E.3
Wauben, M.H.4
Storm, G.5
Van Lent, P.L.6
-
53
-
-
84861660607
-
Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines
-
Ulmansky R, Turjeman K, Baru M et al. Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines. J. Control. Release 160(2), 299-305 (2012).
-
(2012)
J. Control. Release
, vol.160
, Issue.2
, pp. 299-305
-
-
Ulmansky, R.1
Turjeman, K.2
Baru, M.3
-
54
-
-
38149100039
-
Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: A novel approach to treating autoimmune arthritis
-
Avnir Y, Ulmansky R, Wasserman V et al. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. Arthritis Rheumat. 58(1), 119-129 (2008).
-
(2008)
Arthritis Rheumat.
, vol.58
, Issue.1
, pp. 119-129
-
-
Avnir, Y.1
Ulmansky, R.2
Wasserman, V.3
-
55
-
-
58849104833
-
Alphamethylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy
-
Hwang J, Rodgers K, Oliver JC, Schluep T. Alphamethylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy. Int. J. Nanomedicine 3(3), 359-371 (2008).
-
(2008)
Int. J. Nanomedicine
, vol.3
, Issue.3
, pp. 359-371
-
-
Hwang, J.1
Rodgers, K.2
Oliver, J.C.3
Schluep, T.4
-
56
-
-
65649115761
-
Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate
-
Ishihara T, Kubota T, Choi T, Higaki M. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate. J. Pharm. Exp. Ther. 329(2), 412-417 (2009).
-
(2009)
J. Pharm. Exp. Ther.
, vol.329
, Issue.2
, pp. 412-417
-
-
Ishihara, T.1
Kubota, T.2
Choi, T.3
Higaki, M.4
-
57
-
-
77954671356
-
Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis
-
Anderson R, Franch A, Castell M et al. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis. Arthritis Res. Ther. 12(4), R147 (2010).
-
(2010)
Arthritis Res. Ther.
, vol.12
, Issue.4
, pp. R147
-
-
Anderson, R.1
Franch, A.2
Castell, M.3
-
58
-
-
77952539277
-
Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: Long-term suppression of arthritis facilitates interval treatment
-
Rauchhaus U, Schwaiger FW, Panzner S. Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment. Arthritis Res. Ther. 11(6), R190 (2009).
-
(2009)
Arthritis Res. Ther.
, vol.11
, Issue.6
, pp. R190
-
-
Rauchhaus, U.1
Schwaiger, F.W.2
Panzner, S.3
-
59
-
-
33646381864
-
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis
-
Koning GA, Schiffelers RM, Wauben MH et al. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheumat. 54(4), 1198-1208 (2006).
-
(2006)
Arthritis Rheumat.
, vol.54
, Issue.4
, pp. 1198-1208
-
-
Koning, G.A.1
Schiffelers, R.M.2
Wauben, M.H.3
-
60
-
-
84893472683
-
Nanomedicines for inflammatory arthritis: Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes
-
Quan L, Zhang Y, Crielaard BJ et al. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano 8(1), 458-466 (2013).
-
(2013)
ACS Nano
, vol.8
, Issue.1
, pp. 458-466
-
-
Quan, L.1
Zhang, Y.2
Crielaard, B.J.3
-
61
-
-
84905250766
-
Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages
-
Bartneck M, Peters FM, Warzecha KT et al. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages. Nanomedicine 10(6), 1209-1220 (2014).
-
(2014)
Nanomedicine
, vol.10
, Issue.6
, pp. 1209-1220
-
-
Bartneck, M.1
Peters, F.M.2
Warzecha, K.T.3
-
62
-
-
80052323457
-
Folatetargeted nanoparticles show efficacy in the treatment of inflammatory arthritis
-
Thomas TP, Goonewardena SN, Majoros IJ et al. Folatetargeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheumat. 63(9), 2671-2680 (2011).
-
(2011)
Arthritis Rheumat.
, vol.63
, Issue.9
, pp. 2671-2680
-
-
Thomas, T.P.1
Goonewardena, S.N.2
Majoros, I.J.3
-
63
-
-
84873944529
-
Intra-articular methotrexate associated to lipid nanoemulsions: Anti-inflammatory effect upon antigeninduced arthritis
-
Mello SB, Tavares ER, Bulgarelli A, Bonfa E, Maranhao RC. Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigeninduced arthritis. Int. J. Nanomedicine 8, 443-449 (2013).
-
(2013)
Int. J. Nanomedicine
, vol.8
, pp. 443-449
-
-
Mello, S.B.1
Tavares, E.R.2
Bulgarelli, A.3
Bonfa, E.4
Maranhao, R.C.5
-
64
-
-
84922838408
-
Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application
-
Moura CC, Segundo MA, Neves JD, Reis S, Sarmento B. Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application. Int. J. Nanomedicine 9, 4911-4922 (2014).
-
(2014)
Int. J. Nanomedicine
, vol.9
, pp. 4911-4922
-
-
Moura, C.C.1
Segundo, M.A.2
Neves, J.D.3
Reis, S.4
Sarmento, B.5
-
65
-
-
84902139466
-
Sequential optimization of methotrexate encapsulation in micellar nano-networks of polyethyleneimine ionomer containing redox-sensitive crosslinks
-
Abolmaali SS, Tamaddon A, Yousefi G, Javidnia K, Dinarvand R. Sequential optimization of methotrexate encapsulation in micellar nano-networks of polyethyleneimine ionomer containing redox-sensitive crosslinks. Int. J. Nanomedicine 9, 2833-2848 (2014).
-
(2014)
Int. J. Nanomedicine
, vol.9
, pp. 2833-2848
-
-
Abolmaali, S.S.1
Tamaddon, A.2
Yousefi, G.3
Javidnia, K.4
Dinarvand, R.5
-
66
-
-
84919631363
-
Sugarcane bagasse lignin, and silica gel and magneto-silica as drug vehicles for development of innocuous methotrexate drug against rheumatoid arthritis disease in albino rats
-
Wahba SMR, Darwish AS, Shehata IH, Abd Elhalem SS. Sugarcane bagasse lignin, and silica gel and magneto-silica as drug vehicles for development of innocuous methotrexate drug against rheumatoid arthritis disease in albino rats. Mat. Sci. Eng. C 48, 599-610 (2015).
-
(2015)
Mat. Sci. Eng. C
, vol.48
, pp. 599-610
-
-
Wahba, S.M.R.1
Darwish, A.S.2
Shehata, I.H.3
Abd Elhalem, S.S.4
-
67
-
-
84885365131
-
Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis
-
Wilson DR, Zhang N, Silvers AL, Forstner MB, Bader RA. Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis. Eur. J. Pharm. Sci. 51, 146-156 (2014).
-
(2014)
Eur. J. Pharm. Sci.
, vol.51
, pp. 146-156
-
-
Wilson, D.R.1
Zhang, N.2
Silvers, A.L.3
Forstner, M.B.4
Bader, R.A.5
-
68
-
-
77957313563
-
Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosisinducing ligand for treatment of rheumatoid arthritis
-
Kim YJ, Chae SY, Jin CH et al. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosisinducing ligand for treatment of rheumatoid arthritis. Biomaterials 31(34), 9057-9064 (2010).
-
(2010)
Biomaterials
, vol.31
, Issue.34
, pp. 9057-9064
-
-
Kim, Y.J.1
Chae, S.Y.2
Jin, C.H.3
-
69
-
-
84855845432
-
Co-delivery of antigen and a lipophilic antiinflammatory drug to cells via a tailorable nanocarrier emulsion
-
Chuan YP, Zeng BY, O'Sullivan B, Thomas R, Middelberg AP. Co-delivery of antigen and a lipophilic antiinflammatory drug to cells via a tailorable nanocarrier emulsion. J. Colloid Interface Sci. 368(1), 616-624 (2012).
-
(2012)
J. Colloid Interface Sci.
, vol.368
, Issue.1
, pp. 616-624
-
-
Chuan, Y.P.1
Zeng, B.Y.2
O'Sullivan, B.3
Thomas, R.4
Middelberg, A.P.5
-
70
-
-
84866181821
-
Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles
-
Zhou HF, Yan H, Senpan A et al. Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles. Biomaterials 33(33), 8632-8640 (2012).
-
(2012)
Biomaterials
, vol.33
, Issue.33
, pp. 8632-8640
-
-
Zhou, H.F.1
Yan, H.2
Senpan, A.3
-
71
-
-
84907229817
-
Hyaluronan nanoparticles bearing ?-secretase inhibitor: In vivo therapeutic effects on rheumatoid arthritis
-
Heo R, Park J-S, Jang HJ et al. Hyaluronan nanoparticles bearing ?-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis. J. Control. Release 192, 295-300 (2014).
-
(2014)
J. Control. Release
, vol.192
, pp. 295-300
-
-
Heo, R.1
Park, J.-S.2
Jang, H.J.3
-
72
-
-
77950657693
-
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: Results of a Phase 1/2 study
-
Mease PJ, Wei N, Fudman EJ et al. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a Phase 1/2 study. J. Rheumatol. 37(4), 692-703 (2010).
-
(2010)
J. Rheumatol.
, vol.37
, Issue.4
, pp. 692-703
-
-
Mease, P.J.1
Wei, N.2
Fudman, E.J.3
-
73
-
-
33846846570
-
Liposomes for phospholipase A2 triggered siRNA release: Preparation and in vitro test
-
Foged C, Nielsen HM, Frokjaer S. Liposomes for phospholipase A2 triggered siRNA release: preparation and in vitro test. Int. J. Pharm. 331(2), 160-166 (2007).
-
(2007)
Int. J. Pharm.
, vol.331
, Issue.2
, pp. 160-166
-
-
Foged, C.1
Nielsen, H.M.2
Frokjaer, S.3
-
74
-
-
58149215702
-
Chitosan/siRNA nanoparticlemediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model
-
Howard KA, Paludan SR, Behlke MA, Besenbacher F, Deleuran B, Kjems J. Chitosan/siRNA nanoparticlemediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol. Ther. 17(1), 162-168 (2009).
-
(2009)
Mol. Ther.
, vol.17
, Issue.1
, pp. 162-168
-
-
Howard, K.A.1
Paludan, S.R.2
Behlke, M.A.3
Besenbacher, F.4
Deleuran, B.5
Kjems, J.6
-
75
-
-
84055177973
-
Arthritic joint-targeting small interfering RNAencapsulated liposome: Implication for treatment strategy for rheumatoid arthritis
-
Komano Y, Yagi N, Onoue I, Kaneko K, Miyasaka N, Nanki T. Arthritic joint-targeting small interfering RNAencapsulated liposome: implication for treatment strategy for rheumatoid arthritis. J. Pharm. Exp. Ther. 340(1), 109-113 (2012).
-
(2012)
J. Pharm. Exp. Ther.
, vol.340
, Issue.1
, pp. 109-113
-
-
Komano, Y.1
Yagi, N.2
Onoue, I.3
Kaneko, K.4
Miyasaka, N.5
Nanki, T.6
-
76
-
-
33745014998
-
Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis
-
Khoury M, Louis-Plence P, Escriou V et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheumat. 54(6), 1867-1877 (2006).
-
(2006)
Arthritis Rheumat.
, vol.54
, Issue.6
, pp. 1867-1877
-
-
Khoury, M.1
Louis-Plence, P.2
Escriou, V.3
-
77
-
-
84864590087
-
MRIassessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model
-
Te Boekhorst BCM, Jensen LB, Colombo S et al. MRIassessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model. J. Control. Release 161(3), 772-780 (2012).
-
(2012)
J. Control. Release
, vol.161
, Issue.3
, pp. 772-780
-
-
Te Boekhorst, B.C.M.1
Jensen, L.B.2
Colombo, S.3
-
78
-
-
82455217419
-
Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model
-
Scheinman RI, Trivedi R, Vermillion S, Kompella UB. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model. Nanomedicine 6(10), 1669-1682 (2011).
-
(2011)
Nanomedicine
, vol.6
, Issue.10
, pp. 1669-1682
-
-
Scheinman, R.I.1
Trivedi, R.2
Vermillion, S.3
Kompella, U.B.4
-
79
-
-
84892424496
-
Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor ? Chain prevents disease progression in experimental arthritis
-
Zhang T, Bai X, Mao X. Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor ? chain prevents disease progression in experimental arthritis. PLoS ONE 8(11), e78619 (2013).
-
(2013)
PLoS ONE
, vol.8
, Issue.11
, pp. e78619
-
-
Zhang, T.1
Bai, X.2
Mao, X.3
-
80
-
-
45749097402
-
Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis
-
Fernandes JC, Wang H, Jreyssaty C et al. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol. Ther. 16(7), 1243-1251 (2008).
-
(2008)
Mol. Ther.
, vol.16
, Issue.7
, pp. 1243-1251
-
-
Fernandes, J.C.1
Wang, H.2
Jreyssaty, C.3
-
81
-
-
84881184459
-
Temperature-modulated noncovalent interaction controllable complex for the longterm delivery of etanercept to treat rheumatoid arthritis
-
Jung Y-S, Park W, Na K. Temperature-modulated noncovalent interaction controllable complex for the longterm delivery of etanercept to treat rheumatoid arthritis. J. Control. Release 171(2), 143-151 (2013).
-
(2013)
J. Control. Release
, vol.171
, Issue.2
, pp. 143-151
-
-
Jung, Y.-S.1
Park, W.2
Na, K.3
-
82
-
-
84873390528
-
Novel, Biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
-
Sethi V, Rubinstein I, Kuzmis A, Kastrissios H, Artwohl J, Onyuksel H. Novel, Biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis. Mol. Pharm. 10(2), 728-738 (2012).
-
(2012)
Mol. Pharm.
, vol.10
, Issue.2
, pp. 728-738
-
-
Sethi, V.1
Rubinstein, I.2
Kuzmis, A.3
Kastrissios, H.4
Artwohl, J.5
Onyuksel, H.6
-
83
-
-
0033509413
-
Selective expression of folate receptor ? and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis
-
Nakashima-Matsushita N, Homma T, Yu S et al. Selective expression of folate receptor ? and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheumat. 42(8), 1609-1616 (1999).
-
(1999)
Arthritis Rheumat.
, vol.42
, Issue.8
, pp. 1609-1616
-
-
Nakashima-Matsushita, N.1
Homma, T.2
Yu, S.3
-
84
-
-
0036174736
-
Inhibition of LFA-1/ICAM-1 and VLA-4/ VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
-
Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ. Inhibition of LFA-1/ICAM-1 and VLA-4/ VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Medicinal Res. Rev. 22(2), 146-167 (2002).
-
(2002)
Medicinal Res. Rev.
, vol.22
, Issue.2
, pp. 146-167
-
-
Yusuf-Makagiansar, H.1
Anderson, M.E.2
Yakovleva, T.V.3
Murray, J.S.4
Siahaan, T.J.5
-
85
-
-
23944515786
-
Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis
-
Huang M-T, Mason JC, Birdsey GM et al. Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood 106(5), 1636-1643 (2005).
-
(2005)
Blood
, vol.106
, Issue.5
, pp. 1636-1643
-
-
Huang, M.-T.1
Mason, J.C.2
Birdsey, G.M.3
-
86
-
-
79955911075
-
Human vascular endothelial cells: A model system for studying vascular inflammation in diabetes and atherosclerosis
-
Onat D, Brillon D, Colombo P, Schmidt A. Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr. Diab. Rep. 11(3), 193-202 (2011).
-
(2011)
Curr. Diab. Rep.
, vol.11
, Issue.3
, pp. 193-202
-
-
Onat, D.1
Brillon, D.2
Colombo, P.3
Schmidt, A.4
-
87
-
-
0036166975
-
Vasoactive intestinal peptide in the immune system: Potential therapeutic role in inflammatory and autoimmune diseases
-
Delgado M, Abad C, Martinez C et al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med. 80(1), 16-24 (2002).
-
(2002)
J. Mol. Med.
, vol.80
, Issue.1
, pp. 16-24
-
-
Delgado, M.1
Abad, C.2
Martinez, C.3
-
88
-
-
55949094904
-
Current status of gene therapy for rheumatoid arthritis
-
Gaddy D, Robbins P. Current status of gene therapy for rheumatoid arthritis. Curr. Rheumatol. Rep. 10(5), 398-404 (2008).
-
(2008)
Curr. Rheumatol. Rep.
, vol.10
, Issue.5
, pp. 398-404
-
-
Gaddy, D.1
Robbins, P.2
-
89
-
-
84903986902
-
A sight on the current nanoparticle-based gene delivery vectors
-
Dizaj SM, Jafari S, Khosroushahi AY. A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res. Lett. 9(1), 252-252 (2014).
-
(2014)
Nanoscale Res. Lett.
, vol.9
, Issue.1
, pp. 252-252
-
-
Dizaj, S.M.1
Jafari, S.2
Khosroushahi, A.Y.3
-
90
-
-
81255179346
-
Nanoparticles in gene therapy: Principles, prospects, and challenges
-
Antonio V (Ed.). Academic Press, CA, USA
-
Liu C, Zhang N. Nanoparticles in gene therapy: principles, prospects, and challenges. In: Progress in Molecular Biology and Translational Science. Antonio V (Ed.). Academic Press, CA, USA, 509-562 (2011).
-
(2011)
Progress in Molecular Biology and Translational Science
, pp. 509-562
-
-
Liu, C.1
Zhang, N.2
-
91
-
-
84862673737
-
PLGA-based nanoparticles: An overview of biomedical applications
-
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release 161(2), 505-522 (2012).
-
(2012)
J. Control. Release
, vol.161
, Issue.2
, pp. 505-522
-
-
Danhier, F.1
Ansorena, E.2
Silva, J.M.3
Coco, R.4
Le Breton, A.5
Préat, V.6
-
92
-
-
69249150822
-
A Nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo
-
Yagi N, Manabe I, Tottori T et al. A Nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo. Cancer Res. 69(16), 6531-6538 (2009).
-
(2009)
Cancer Res.
, vol.69
, Issue.16
, pp. 6531-6538
-
-
Yagi, N.1
Manabe, I.2
Tottori, T.3
-
93
-
-
0030763774
-
How TRAIL kills cancer cells, but not normal cells
-
Gura T. How TRAIL kills cancer cells, but not normal cells. Science 277(5327), 768 (1997).
-
(1997)
Science
, vol.277
, Issue.5327
, pp. 768
-
-
Gura, T.1
-
94
-
-
84902057555
-
Apoptosis in cancer: Mechanisms, deregulation, and therapeutic targeting
-
Neidle S (Ed.). Academic Press, CA, USA
-
Siddik ZH. apoptosis in cancer: mechanisms, deregulation, and therapeutic targeting. In: Cancer Drug Design and Discovery (2nd Edition). Neidle S (Ed.). Academic Press, CA, USA, 357-390 (2014).
-
(2014)
Cancer Drug Design and Discovery (2nd Edition)
, pp. 357-390
-
-
Siddik, Z.H.1
-
95
-
-
84921677208
-
Two deathinducing human TRAIL receptors to target in cancer: Similar or distinct regulation and function?
-
Van Roosmalen IaM, Quax WJ, Kruyt FaE. Two deathinducing human TRAIL receptors to target in cancer: similar or distinct regulation and function? Biochem. Pharmacol. 91(4), 447-456 (2014).
-
(2014)
Biochem. Pharmacol.
, vol.91
, Issue.4
, pp. 447-456
-
-
Van Roosmalen Ia, M.1
Quax, W.J.2
Kruyt FaE.3
-
96
-
-
77649190268
-
TRAILing death in cancer
-
Mellier G, Huang S, Shenoy K, Pervaiz S. TRAILing death in cancer. Mol. Aspects Med. 31(1), 93-112 (2010).
-
(2010)
Mol. Aspects Med.
, vol.31
, Issue.1
, pp. 93-112
-
-
Mellier, G.1
Huang, S.2
Shenoy, K.3
Pervaiz, S.4
-
98
-
-
65449152836
-
Following TRAIL's path in the immune system
-
Falschlehner C, Schaefer U, Walczak H. Following TRAIL's path in the immune system. Immunology 127(2), 145-154 (2009).
-
(2009)
Immunology
, vol.127
, Issue.2
, pp. 145-154
-
-
Falschlehner, C.1
Schaefer, U.2
Walczak, H.3
-
99
-
-
38649123297
-
RGD-avidin-biotin pretargeting to ?V?3 integrin enhances the proapoptotic activity of TNF? Related apoptosis inducing ligand (TRAIL)
-
Tarrus M, Sloot A, Temming K et al. RGD-avidin-biotin pretargeting to ?v?3 integrin enhances the proapoptotic activity of TNF? related apoptosis inducing ligand (TRAIL). Apoptosis 13(2), 225-235 (2008).
-
(2008)
Apoptosis
, vol.13
, Issue.2
, pp. 225-235
-
-
Tarrus, M.1
Sloot, A.2
Temming, K.3
-
100
-
-
84898788471
-
Nanomedicines: Addressing the scientific and regulatory gap
-
Tinkle S, Mcneil SE, Mühlebach S et al. Nanomedicines: addressing the scientific and regulatory gap. Ann. NY Acad. Sci. 1313(1), 35-56 (2014).
-
(2014)
Ann. NY Acad. Sci.
, vol.1313
, Issue.1
, pp. 35-56
-
-
Tinkle, S.1
Mcneil, S.E.2
Mühlebach, S.3
|